The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
G | Genito urinary system and sex hormones | |
2
|
G04 | Urologicals | |
3
|
G04B | Other urologicals, incl. antispasmodics | |
4
|
G04BD | Urinary antispasmodics | |
5
|
G04BD13 |
| Active Ingredient |
|---|
|
Desfesoterodine is a competitive, specific muscarinic receptor antagonist. It is the primary active metabolite of fesoterodine, and regarded as main active pharmacological principle of fesoterodine; fesoterodine is considered as prodrug of desfesoterodine. The affinity of desfesoterodine for the muscarinic receptors is 2 orders of magnitude greater than that of fesoterodine. |
| Document | Type | Information Source | |
|---|---|---|---|
| TOVEDESO Prolonged-release tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.